Article

Evaluation of the ID NOW Among Symptomatic Individuals During the Omicron Wave

2022-05-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Point of Care SARS-CoV-2 devices, such as the Abbott ID NOW have great potential, to help combat the COVID-19 pandemic. Starting in December, 2020, the ID NOW was implemented throughout the province of Alberta, Canada (population 4.4 million) in various settings. We aimed to assess the ID NOW performance during the BA.1 Omicron wave and compare it to previous waves. <h4>METHOD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a47dc98d-d4f7-5bdb-b214-3f88a83a08e2
DOI: 10.1101/2022.05.19.22275316

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the ID NOW Among Symptomatic Individuals During the Omicron WaveDOI 10.1101/2022.05.19.22275316Read

Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic IndividualsSemantic proximity Read

Relative Sensitivity of ID NOW and RT-PCR for Detection of SARS-CoV-2 in an Ambulatory Population: Clinical Evaluation, Systematic Review and Meta-analysisSemantic proximity Read

Acceptable Performance of the Abbott ID NOW Among Symptomatic Individuals with Confirmed COVID-19Semantic proximity Read

Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice – a prospective multicenter validation and implementation studySemantic proximity Read

CovidNudge: diagnostic accuracy of a novel lab-free point-of-care diagnostic for SARS-CoV-2Semantic proximity Read

Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.Semantic proximity Read

Determinants for detection of infection with SARS-CoV-2 Omicron variants of concern in health care workers by rapid antigen testsSemantic proximity Read

Analytical performance of rapid antigen tests for the detection of SARS-CoV-2 during widespread circulation of the Omicron variantSemantic proximity Read

Finding a Needle in a Haystack: Design and Implementation of a Digital Site-less Clinical Study of Serial Rapid Antigen Testing to Identify Asymptomatic SARS-CoV-2 InfectionSemantic proximity Read

Comparison of Rapid Antigen Tests’ Performance between Delta (B.1.61.7; AY.X) and Omicron (B.1.1.529; BA1) Variants of SARS-CoV-2: Secondary Analysis from a Serial Home Self-Testing StudySemantic proximity Read

LESSONS FROM THE COVID-19 THIRD WAVE IN CANADA: THE IMPACT OF VARIANTS OF CONCERN AND SHIFTING DEMOGRAPHICSSemantic proximity Read

Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patientsSemantic proximity Read